0001193125-25-123693.txt : 20250623 0001193125-25-123693.hdr.sgml : 20250623 20250521090658 ACCESSION NUMBER: 0001193125-25-123693 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rein Therapeutics, Inc. CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 134196017 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 12407 N. MOPAC EXPY. STREET 2: SUITE 250 #390 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 7378021989 MAIL ADDRESS: STREET 1: 12407 N. MOPAC EXPY. STREET 2: SUITE 250 #390 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: Aileron Therapeutics, Inc. DATE OF NAME CHANGE: 20240329 FORMER COMPANY: FORMER CONFORMED NAME: AILERON THERAPEUTICS INC DATE OF NAME CHANGE: 20071207 CORRESP 1 filename1.htm CORRESP

REIN THERAPEUTICS, INC.

12407 N. Mopac Expy., Suite 250 #390

Austin, Texas 78758

May 21, 2025

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Christopher Edwards

 

Re:

Rein Therapeutics, Inc.

Registration Statement on Form S-3

File No. 333-287342

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Rein Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-287342), so that it may become effective at 4:00 p.m. Eastern time on May 22, 2025, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.

 

Very truly yours,
REIN THERAPEUTICS, INC.
By:  

/s/ Brian Windsor

Name:   Brian Windsor, Ph.D.
Title:   President and Chief Executive Officer

 

cc:

Stuart Falber, Wilmer Cutler Pickering Hale and Dorr LLP

Molly Fox, Wilmer Cutler Pickering Hale and Dorr LLP